WO1998014162A1 - Agent permettant d'agir sur l'organisme - Google Patents

Agent permettant d'agir sur l'organisme Download PDF

Info

Publication number
WO1998014162A1
WO1998014162A1 PCT/RU1997/000305 RU9700305W WO9814162A1 WO 1998014162 A1 WO1998014162 A1 WO 1998014162A1 RU 9700305 W RU9700305 W RU 9700305W WO 9814162 A1 WO9814162 A1 WO 9814162A1
Authority
WO
WIPO (PCT)
Prior art keywords
isχοdnοgο
veschesτva
πρi
ποlzuyuτ
sρedsτvο
Prior art date
Application number
PCT/RU1997/000305
Other languages
English (en)
Russian (ru)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Priority to AU47293/97A priority Critical patent/AU4729397A/en
Priority to UA99042270A priority patent/UA57042C2/uk
Priority to EA199900298A priority patent/EA001601B1/ru
Publication of WO1998014162A1 publication Critical patent/WO1998014162A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Definitions

  • the invention of the field of medicine can be used for the treatment and treatment of alcoholism, drug abuse, and to increase the protection of the drug.
  • Medicinal products known to be associated with other diseases are known to be associated with toxic substances for the treatment of allergic diseases. (see pr. Elkogolism (manuals for physicians), Iodine, ed. G.K. ⁇ zova and others. ⁇ ., Meditsina, 1983, p.322-329). However, these devices are subject to limited use and often cause adverse effects.
  • Lactate gastric mucosal function etc. (see St. Louis ⁇ ⁇ ° 2039556, cl. ⁇ 61 ⁇ 31/19, 1995). ⁇ the lack of accessibility of the possibility of the possibility of manifestations of adverse events, depending on the effectiveness of individual sensitivity.
  • substances are selected that are, by all means, with toxic properties.
  • ethanol is used, and for the treatment of alcoholism as a source of diabetes, it is used
  • any well-known home club For treatment ⁇ ime ⁇ I ⁇ niches ⁇ g ⁇ m ⁇ inizma ⁇ entsi ⁇ van- ny ⁇ e ⁇ a ⁇ a ⁇ ⁇ ig ⁇ vlyayu ⁇ ⁇ u ⁇ em mn ⁇ g ⁇ a ⁇ n ⁇ g ⁇ ⁇ sled ⁇ - va ⁇ eln ⁇ g ⁇ ⁇ azvedeniya and vs ⁇ ya ⁇ ivaniya ⁇ g ⁇ me ⁇ a ⁇ iches ⁇ - mu me ⁇ du of is ⁇ dn ⁇ g ⁇ ⁇ sichn ⁇ g ⁇ vesches ⁇ va ⁇ iyn ⁇ g ⁇ ⁇ al ⁇ ida-alkyl or m ⁇ ina m ⁇ ina gid ⁇ l ⁇ ida and ⁇ i ⁇ yvayu ⁇ I ⁇ a ⁇ ley ⁇ eimusches ⁇ venn ⁇ s ⁇ enn ⁇ m ⁇ azvedenii 100 (C 100) gruanulu from sahara.
  • Potentially disinfecting device is separately prepared in the form of granules from sugar, processed alimentary preparations, ⁇ ime ⁇ 5 P ⁇ i is ⁇ lz ⁇ vanii zayavlenn ⁇ g ⁇ s ⁇ eds ⁇ va v ⁇ zdeys ⁇ - Via on ⁇ gayizm in ⁇ aches ⁇ ve an ⁇ id ⁇ a ⁇ entsi ⁇ uyu ⁇ is ⁇ d- n ⁇ e ⁇ siches ⁇ e vesches ⁇ v ⁇ , na ⁇ ime ⁇ , ⁇ a ⁇ y-lib ⁇ yad ⁇ imi- ⁇ a ⁇ ⁇ i ⁇ a ⁇ l ⁇ s or b ⁇ mis ⁇ y me ⁇ il, ⁇ u ⁇ or svi- Heff or ⁇ avlyayuschee vesches ⁇ v ⁇ , na ⁇ ime ⁇ , i ⁇ i ⁇ ⁇ u ⁇ em mn ⁇ g ⁇ a ⁇ n ⁇ g ⁇ Dilutions and shakes or growths at home and apply I on the basis of the

Landscapes

  • Health & Medical Sciences (AREA)
  • Addiction (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Cette invention concerne un agent permettant d'agir sur l'organisme et se rapporte à des substances actives sur le plan biologique. Cette invention concerne plus particulièrement une préparation potentialisée, laquelle est obtenue en cultivant et en remuant plusieurs fois un produit de départ concret qui possède des propriétés toxiques et qui est nocif à l'organisme (narcotiques, alcool, nicotine, poisons industriels, substances militaires nocives). Afin de soigner l'alcoolisme, on utilise de l'éthanol en qualité de substance de départ au moment de la potentialisation, tandis que l'on utilise un alcaloïde d'opium, de la morphine ou de l'hydrochlorure de morphine afin de soigner les problèmes de drogue. Cet agent potentialisé peut être utilisé sous toute forme médicamenteuse homéopathique et, de préférence, avec le produit de départ.
PCT/RU1997/000305 1996-09-30 1997-09-29 Agent permettant d'agir sur l'organisme WO1998014162A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU47293/97A AU4729397A (en) 1996-09-30 1997-09-29 Agent for acting upon the organism
UA99042270A UA57042C2 (uk) 1996-09-30 1997-09-29 Засіб впливу на організм
EA199900298A EA001601B1 (ru) 1996-09-30 1997-09-29 Средство для воздействия на организм

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU96118931A RU2132181C1 (ru) 1996-09-30 1996-09-30 Средство для воздействия на организм
RU96118931 1996-09-30

Publications (1)

Publication Number Publication Date
WO1998014162A1 true WO1998014162A1 (fr) 1998-04-09

Family

ID=20185731

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU1997/000305 WO1998014162A1 (fr) 1996-09-30 1997-09-29 Agent permettant d'agir sur l'organisme

Country Status (5)

Country Link
AU (1) AU4729397A (fr)
EA (1) EA001601B1 (fr)
RU (1) RU2132181C1 (fr)
UA (1) UA57042C2 (fr)
WO (1) WO1998014162A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700096B2 (en) 2002-08-02 2010-04-20 Oleg Iliich Epshtein Medicinal agent for treating erectile dysfunction
US8071630B2 (en) 2002-02-28 2011-12-06 Reinhard Michael Kuzeff Treatment of effect of chemicals with their ultradilute stereoisomers
US8535664B2 (en) 2000-06-20 2013-09-17 Oleg I. Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US8637030B2 (en) 2010-07-15 2014-01-28 Oleg I. Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
RU2541167C2 (ru) * 2013-03-29 2015-02-10 Александр Николаевич Куршев Способ лечения аддикции
US9522116B2 (en) 2006-03-13 2016-12-20 Oleg Iliich Epshtein Solid oral form of a medicinal preparation and a method for the production thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150283148A1 (en) * 2014-02-25 2015-10-08 Anatoly Zazulia Arrangement of specific antidotes with allopathic medicinal preparations in general secondary package

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2030910C1 (ru) * 1994-08-11 1995-03-20 Григорий Семенович Черныш Средство для воздействия на организм
RU2043768C1 (ru) * 1994-05-24 1995-09-20 Алексей Владимирович Попов Способ лечения алкоголизма
RU2074700C1 (ru) * 1993-03-10 1997-03-10 Наталья Борисовна Зубова Способ получения биологически активного препарата
RU2084217C1 (ru) * 1996-02-12 1997-07-20 Эпштейн Олег Ильич Лекарственное средство

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2074700C1 (ru) * 1993-03-10 1997-03-10 Наталья Борисовна Зубова Способ получения биологически активного препарата
RU2043768C1 (ru) * 1994-05-24 1995-09-20 Алексей Владимирович Попов Способ лечения алкоголизма
RU2030910C1 (ru) * 1994-08-11 1995-03-20 Григорий Семенович Черныш Средство для воздействия на организм
RU2084217C1 (ru) * 1996-02-12 1997-07-20 Эпштейн Олег Ильич Лекарственное средство

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHAN BUARON, "Neskolko Utochneny K Razlichnym Tipam Gomeopaticheskikh Razvedeny", Gomeopaticheskaya Farmatseya, Ukrainsky Gomeopatichesky Zhurnal, No. 2, 1992, pages 47-51. *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535664B2 (en) 2000-06-20 2013-09-17 Oleg I. Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US8871203B2 (en) 2000-06-20 2014-10-28 Oleg I. Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US8894995B2 (en) 2000-06-20 2014-11-25 Oleg Iliich Epshtein Method of treating a disorder or condition of viral etiology
US9200081B2 (en) 2000-06-20 2015-12-01 Oleg Iliich Epshtein Method for administering homeopathically potentiated antibodies against mediator of inflammation
US9382332B2 (en) 2000-06-20 2016-07-05 Oleg Iliich Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US8071630B2 (en) 2002-02-28 2011-12-06 Reinhard Michael Kuzeff Treatment of effect of chemicals with their ultradilute stereoisomers
US7700096B2 (en) 2002-08-02 2010-04-20 Oleg Iliich Epshtein Medicinal agent for treating erectile dysfunction
US8168182B2 (en) 2002-08-02 2012-05-01 Oleg Iliich Epshtein Method for treating erectile dysfunction
US9522116B2 (en) 2006-03-13 2016-12-20 Oleg Iliich Epshtein Solid oral form of a medicinal preparation and a method for the production thereof
US8637030B2 (en) 2010-07-15 2014-01-28 Oleg I. Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
RU2541167C2 (ru) * 2013-03-29 2015-02-10 Александр Николаевич Куршев Способ лечения аддикции

Also Published As

Publication number Publication date
EA199900298A1 (ru) 1999-08-26
AU4729397A (en) 1998-04-24
EA001601B1 (ru) 2001-06-25
UA57042C2 (uk) 2003-06-16
RU2132181C1 (ru) 1999-06-27

Similar Documents

Publication Publication Date Title
CN104958752B (zh) 退行性关节病的治疗
CA2417867C (fr) Procedes servant a prevenir ou a traiter des maladies et des etats au moyen de glucides complexes
JPS6160615A (ja) 医薬品
WO1997028776A1 (fr) Medicament et procede d'action medicamenteuse sur l'organisme
WO1998014162A1 (fr) Agent permettant d'agir sur l'organisme
WO2010109417A1 (fr) Crème médicinale antibactérienne et son procédé de production
US20120142631A1 (en) Medicinal antidiaper rash cream incorporating a biopolymer and a process to make it
DK2476420T3 (en) A pharmaceutical composition having antimicrobial activity and rapid healing for external application as well as process for their preparation
JPH04288017A (ja) にきび用化粧料
JPH03503648A (ja) 磁気により作用する同種療法薬ならびにそれらの製造方法およびそれらの投与方法
Packer et al. Getting Ahead of Head Lice: Treatment in the Setting of Resistance.
RU2443427C1 (ru) Антигельминтное средство
EP3087990B1 (fr) Poudre gélifiante contenant du sulfamonométhoxine et du chitosane destinée au traitement des plaies
RU2177327C2 (ru) Фито-препарат "мастоцид" для лечения мастита у сельскохозяйственных животных
US20110311642A1 (en) Composition and method for oral delivery of cobra venom
WO2002074311A1 (fr) Preparation medicinale antitumorale, antivirale, antibacterienne, antiparasitaire, anti-inflammatoire, antifongique et immunomodulatrice, procede de fabrication et formes de medicaments
WO2001058464A1 (fr) Forme posologique d'ivermectine a dispersion aqueuse utilisee pour soigner ectoparasitose et endoparasitose
RU2070409C1 (ru) Препарат для лечения мастита у лактирующих животных
WO2010119383A1 (fr) Crème médicinale fabriquée à l'aide de crème de sulfate de framycétine et de chitosane, et procédé pour la fabriquer
RU2682454C1 (ru) Мазь для лечения термических ожогов и способ их лечения
Chernyshev Of tutu and bugs
Nikiforova et al. Recipe of veterinary medicine
RU2591805C2 (ru) Средство для профилактики и лечения заболеваний опорно-двигательного аппарата
CN115844925A (zh) 一种含利多卡因的抗菌镇痛剂及其制备方法
WO2005041952A1 (fr) Composition pharmaceutique possedant une activite cerebrale vasodilatatrice et nootropique

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 199900298

Country of ref document: EA

NENP Non-entry into the national phase

Ref document number: 1998516416

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA